Phase I Cancer Clinical Trials: A Practical Guide

— —

Elizabeth A. Eisenhauer (Head, Department of Oncology; Medical Director, Oncology Program, Queen's University, Kingston General Hospital, Cancer Centre of Southeastern Ontario) Christopher Twelves (Professor of Clinical Pharmacology and Oncology; Head, Section of Clinical Cancer Research Groups, Leeds Institute of Molecular Medicine, St. James's Institute of Oncology)

Phase I Cancer Clinical Trials

A Practical Guide

Elizabeth A. Eisenhauer (Head, Department of Oncology; Medical Director, Oncology Program, Queen's University, Kingston General Hospital, Cancer Centre of Southeastern Ontario), Christopher Twelves (Professor of Clinical Pharmacology and Oncology; Head, Section of Clinical Cancer Research Groups, Leeds Institute of Molecular Medicine, St. James's Institute of Oncology), Marc Buyse (Founder and Chairman; Associate Professor of Biostatistics, International Drug Development Institute; Universiteit Hasselt)

$154.95

Paperback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

Oxford University Press Inc
01 June 2014

Oncology; Haematology; Pharmacology

Phase I trials are a critical first step in the study of novel cancer therapeutic approaches. Their primary goals are to identify the recommended dose, schedule and pharmacologic behavior of new agents or new combinations of agents and to describe the adverse effects of treatment. In cancer therapeutics, such studies have particular challenges. Due to the nature of the effects of treatment, most such studies are conducted in patients with advanced malignancy, rather than in healthy volunteers. Further, the endpoints of these trials are usually measures adverse effects rather than molecular target or anti-tumor effects. These factors render the design, conduct, analysis and ethical aspects of phase I cancer trials unique. As the only comprehensive book on this topic, Phase I Cancer Clinical Trials is a useful resource for oncology trainees or specialists interested in understanding cancer drug development. New to this edition are chapters on Phase 0 Trials and Immunotherapeutics, and updated information on the process, pitfalls, and logistics of Phase I Trials

Edited by: Elizabeth A. Eisenhauer (Head Department of Oncology; Medical Director Oncology Program Queen's University Kingston General Hospital Cancer Centre of Southeastern Ontario), Christopher Twelves (Professor of Clinical Pharmacology and Oncology; Head, Section of Clinical Cancer Research Groups, Leeds Institute of Molecular Medicine, St. James's Institute of Oncology), Marc Buyse (Founder and Chairman; Associate Professor of Biostatistics, International Drug Development Institute; Universiteit Hasselt)
Imprint: Oxford University Press Inc
Country of Publication: United States
Edition: 2nd Revised edition
Dimensions: Height: 234mm, Width: 156mm, Spine: 17mm
Weight: 522g
ISBN: 9780199359011
ISBN 10: 0199359016
Pages: 368
Publication Date: 01 June 2014
Audience: Professional and scholarly , Undergraduate
Format: Paperback
Publisher's Status: Active

1. Introduction ; 2. Preclinical Data and Requirements ; 3. Phase 0 Clinical Trials ; 4. Basics of Phase I Design: First-in-man Studies ; 5. Ethical Issues in First-in-human Phase I Cancer Trials ; 6. Phase I Trials in Special Populations and Circumstances ; 7. Phase I Trials of Immunotherapeutics ; 8. Statistical Designs for First-in-human Phase I Trials ; 9. Writing the Protocol ; 10. Practical Aspects of Pharmacokinetics and Pharmacodynamics ; 11. Process, Pitfalls, and Logistics of Phase I Trials ; 12. Reporting and Interpreting Results ; Appendix: Useful Web Resources

EAE: Head, Department of Oncology, Queen's University, Medical Director, Oncology Program, Kingston General Hospital, Cancer Centre of Southeastern Ontario, Kingston, Canada; CT: Professor of Clinical Pharmacology and Oncology, Head, Section of Clinical Cancer Research Groups, Leeds Institute of Cancer Studies and Pathology, St. James's Institute of Oncology Leeds, UK; MB: Founder and Chairman, International Drug Development Institute, Louvain-la-Neuve, Belgium, Associate Professor of Biostatistics, Universiteit Hasselt Diepenbeek, Belgium

Reviews for Phase I Cancer Clinical Trials: A Practical Guide

This is a well-written, well-structured book that comprehensively covers the unique aspects of phase I clinical trials in cancer patients. This may be the only book of its kind and will be appropriate for a wide audience. Karen L. Reckamp, MD, MS; Doodys Reviews